Clinical Trial

Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery

Study acronym: BTX and LADD
Completed
View on ClinicalTrials.gov →
Summary
The current study aimed to evaluate the effectiveness of fractional laser treatment alone and fractional laser combined with botulinum toxin A, delivered either through injections or topical application fractional laser-assisted drug delivery (FLADD) in hypertrophic burn scar
Trial Details
NCT Number NCT07360483
Lead Sponsor Cairo University
Conditions Hypertrophic Scars
Enrollment 48 participants
Start Date 2025-01-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-22